Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer

Author:

Liu Juan12345,Chen Chao1,Wei Tuo1234,Gayet Odile6,Loncle Céline6,Borge Laurence6,Dusetti Nelson6,Ma Xiaowei234,Marson Domenico7,Laurini Erik7,Pricl Sabrina78,Gu Zhongwei9,Iovanna Juan6,Peng Ling1ORCID,Liang Xing‐Jie234ORCID

Affiliation:

1. CNRS, Centre Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Equipe Labellisée Ligue Contre le Cancer Aix‐Marseille Université Marseille France

2. Laboratory of Controllable Nanopharmaceuticals Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience Beijing China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology of China Beijing China

4. University of Chinese Academy of Sciences Beijing China

5. Hepato‐Pancreato‐Biliary Center, Beijing Tsinghua Changgung Hospital, School of Medicine Tsinghua University Beijing China

6. Centre de Recherche en Cancérologie de Marseille, INSERM, UMR1068 Marseille France

7. Molecular Biology and Nanotechnology Laboratory (MolBNL@UniTS), DEA University of Trieste Trieste Italy

8. Department of General Biophysics, Faculty of Biology and Environmental Protection University of Lodz Lodz Poland

9. National Engineering Research Center for Biomaterials Sichuan University Chengdu China

Funder

Chinese Academy of Sciences

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3